NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on b...
Karyopharm Therapeutics Competitors or Alternatives
Karyopharm Therapeutics's top competitors include CTI BioPharma, Constellation and AbbVie.
Karyopharm Therapeutics VS CTI BioPharma
CTI BioPharma is Karyopharm Therapeutics's biggest rival. CTI BioPharma was founded in Seattle, Washington} in 1991. Like Karyopharm Therapeutics, CTI BioPharma also competes in the Pharmaceuticals sector. Compared to Karyopharm Therapeutics, CTI BioPharma generates $69.5M less revenue.
Karyopharm Therapeutics VS Constellation
Constellation is Karyopharm Therapeutics's #2 rival. Constellation's headquarters is in Cambridge, Massachusetts, and was founded in 2008. Like Karyopharm Therapeutics, Constellation also competes in the Pharmaceuticals space. Constellation generates 2.07% of Karyopharm Therapeutics's revenue.
Looking for similar companies to Karyopharm Therapeutics?
Similar Companies
Pharmaceuticals companies in Newton
See 12 companies
Companies in Newton with employees in 250-500 rangeSee 23 companies
Biotechnology companies in NewtonSee 16 companies
Pharmaceuticals & Biotechnology companies in NewtonSee 24 companies
Biotechnology companies with revenue in $100-500M rangeSee 234 companies
Pharmaceuticals companies with revenue in $100-500M rangeSee 298 companies
Biotechnology companies with employees in 250-500 rangeSee 340 companies
Pharmaceuticals companies with employees in 250-500 rangeSee 347 companies
Pharmaceuticals companies in Greater BostonSee 500 companies
Trending News for Karyopharm Therapeutics and Karyopharm Therapeutics's Competitors
New York, New York--(Newsfile Corp. - April 14, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ger...
Sandoz Group AG SDZNY SDZXF on Monday filed an antitrust lawsuit in the U.S. against Amgen, Inc. AMGN for extending and entrenching the dominant market...
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....
AbbVie is scheduled to report its first-quarter results this month, with analysts anticipating a modest growth in earnings....
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies invest...
With UPLIZNA receiving a label expansion that opens the door to a previously untapped rare disease market, Amgen is seeing strong returns on its USD 27...
East Hanover, N.J. - In a major show of commitment to its largest market, global pharmaceutical giant Novartis announced on Wednesday a sweeping $23 bi...
/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GP...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Geron To Contact ...
Frequently Asked Questions about Karyopharm Therapeutics
Who are Karyopharm Therapeutics's top competitors?
Karyopharm Therapeutics's top 3 competitors are CTI BioPharma, Constellation, AbbVie.Who is similar to Karyopharm Therapeutics?
CTI BioPharma is the most similar to Karyopharm Therapeutics. Constellation and AbbVie are also similar to Karyopharm Therapeutics.
Are Karyopharm Therapeutics and CTI BioPharma competitors?
Yes, CTI BioPharma is one of Karyopharm Therapeutics’s top competitors.